TITLE

SHAMAN PRODUCTS POISED TO PREVENT MULTIPLE FORMS OF CANCER

PUB. DATE
January 2001
SOURCE
Worldwide Biotech;Jan2001, Vol. 13 Issue 1, p3
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Reports that the SP49400 standardized botanical product from Shaman Pharmaceuticals Inc., which is being formulated on its products, is poised to help prevent colorectal cancer and multiple forms of other cancers by lowering insulin levels through weight loss.
ACCESSION #
4060561

 

Related Articles

  • Pharmaceuticals from the rainforest.  // In Business;Jan/Feb99, Vol. 21 Issue 1, p39 

    Reports that Shaman Pharmaceuticals Inc. has received approval to begin phase one human clinical testing of its antiviral drug SP-303. Potential treatment for herpes, flu and respiratory conditions; Performance of the company.

  • SHAMAN TO LAUNCH NEW WEIGHT LOSS PRODUCT.  // Biotech Business;Sep2000, Vol. 13 Issue 9, p2 

    Announces the plans of Shaman.com, operating division of Shaman Pharmaceuticals Inc., to introduce a weight loss product that contains an ingredient from plant species in the tropical areas of Africa, Asia and Latin America.

  • Shaman switches gears. Brower, Vicki // Nature Biotechnology;Mar1999, Vol. 17 Issue 3, p211 

    Reports that San Francisco, California-based Shaman Pharmaceuticals Inc. has halted its pharmaceuticals business. Percentage reduction in the company's work force; Plan of the company to focus on its private botanicals business.

  • Shaman Exits Pharmaceuticals.  // Chemical Market Reporter;02/08/99, Vol. 255 Issue 6, p13 

    Reports on the decision of Shaman Pharmaceuticals Inc. to withdraw from the pharmaceuticals business. Implication of the move; Negotiation for a possible business partner to outlicense SP-303/Provir; Strategy for Provir treatment of patients with diarrhea.

  • Take a Virtual Expedition to the Peruvian Rain Forest.  // Odyssey;Feb2001, Vol. 10 Issue 2, p42 

    Discusses the founding of The Healing Forest Conservancy by San Francisco, California-based Shaman Pharmaceuticals and its efforts to promote the long-term survival of Peru's tropical forests and cultural diversity of its forest peoples through the Bara's Rainforest Cultural Enrichment Program.

  • Patient advocate. Jaquiss, Ian // Pharmaceutical Executive;Jul98, Vol. 18 Issue 7, p90 

    Reports that Shaman Pharmaceuticals has hired Dallabrida & Associates, a marketing consulting firm, for projects related to SP-303/Provir. Information on SP-303/Provir.

  • Java jive. Dravo, Ed // FW;8/16/94, Vol. 163 Issue 17, p78 

    Comments on the financial performances of the Starbucks Coffee Co. and Shaman Pharmaceuticals Incorporated. Product prices; Stock performances; Forecasted revenues.

  • SP-303/Provir receives fast track designation.  // Drug Store News;6/22/98, Vol. 20 Issue 9, pCP12 

    Announces that the antidiarrheal product manufactured by Shaman Pharmaceuticals Inc. called SP303/Provir has received Fast Track Product designation. Use of drug as treatment of diarrhea in patients with AIDS.

  • Shaman offers good investment and good karma. Fulman, Ricki // Pensions & Investments;12/28/1998, Vol. 26 Issue 26, p8 

    Reports that Shaman Pharmaceuticals Inc. has raised $7.2 million in private offering by committing 3.6 percent donation from future sales of its SP-303 Provir drug to charities. Help to people with AIDS/HIV; Investment through Vulcan Ventures.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics